Why Hexo (TSX:HEXO) Stock Fell 8.4% Last Month

Should you buy Hexo (TSX:HEXO) stock after its 60% decline in 2020?

| More on:

Shares of cannabis company Hexo (TSX:HEXO)(NYSE:HEXO) fell over 8% in September 2020 to close trading at $0.87. While there was no company-specific news that dragged Hexo stock lower, the company was impacted by overall market weakness and the less-than-impressive results of Aurora Cannabis.

However, Hexo has been one of the worst-performing pot stocks in 2020 and has lost 60% in market value this year. Hexo stock is also trading 92% below its record high of $7.75 that it touched in May 2019.

Will Hexo manage to recover its massive losses and stage a comeback over the next few months, or will it continue to trade lower?

Hexo has managed to double its sales in the last three quarters

Hexo is one of the largest weed producers in the world. In the first three quarters of fiscal 2020, the company almost doubled gross sales to $74 million, up from $38.7 million in the prior-year period. It continues to lead the market in Quebec with a market share of 33%.

However, similar to pot peers, Hexo is also grappling with structural issues. In 2018, Hexo signed a multi-year deal with Quebec to supply an aggregate of 200,000 kg of marijuana products in the province. It also acquired Newstrike Brands to bolster annual production capacity to 150,000 kg. Comparatively. it just sold 25,400 kg of products in the last 12 months.

Hexo had to sell the Niagara facility it acquired via Newstrike for $10.2 million. The oversupply issues coupled with overvalued acquisitions contributed to a $42 million write-down in unsold inventory as well as $112 million in goodwill impairment charges in 2020.

What’s next for Hexo investors?

Hexo’s sales have been impacted by increasing competition, which includes a thriving black market. Hexo, in fact, launched the Original Stash brand last year to take on black market sales, which accounted for 40% of total recreational sales in Canada.

Original Stash is a low-cost product that contains high levels of THC, the psychoactive compound in recreational marijuana. Hexo is focused on three production aspects that include high-potent products, value or affordable brands, and mass production of low-grade cannabis to compete with sales in the black market.

Another reason to remain optimistic about Hexo’s long-term prospects is its joint venture with Molson Coors Canada. Hexo has entered the cannabis beverages segment, and in August it announced the two companies will launch five more beverage brands in the upcoming months.

In the last reported quarter, Hexo’s net sales grew 70% year over year to $22.1 million, driven by strong demand for its value brand Original Stash. However, the company’s gross profit stood at a mere $2.4 million and Hexo reported an operating loss of $21.1 million, significantly higher than its loss of $2.2 million in the prior-year period.

The Foolish takeaway

Hexo is trading below $1 a share on the NYSE since March 2020 and received a delisting notice in April. It has until December to get its stock price higher than $1, or it will have to undergo a reverse stock split to continue trading on the exchange.

Further, Hexo will have to improve profit margins over the next few quarters in order to reduce cash burn. Analysts tracking Hexo have a 12-month price target of $1.5, which is 75% above its current trading price. However, as seen above, investing in Hexo carries significant risks right now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »